Rabbit anti-thymocyte globulin

Evidence for clinical benefit in high immunological risk kidney transplantation

Martin Mai, Hani Wadei, Thomas A. Gonwa

Research output: Contribution to journalArticle

Abstract

Rabbit anti-thymocyte globulin is used worldwide to treat and prevent rejection in kidney transplantation. Multiple mechanisms of action of this polyclonal preparation are responsible for its success. Studies have supported clinical benefits of rabbit anti-thymocyte globulin in high immunological risk kidney transplant recipients when used as an induction agent at the time of transplant and for treatment of rejection when compared to other antibody therapy. The evidence of this clinical benefit will be reviewed in addition to examining the dosing and safety profile of rabbit anti-thymocyte globulin.

Original languageEnglish (US)
Pages (from-to)39-49
Number of pages11
JournalClinical Medicine Insights: Therapeutics
Volume3
DOIs
StatePublished - 2011

Fingerprint

Antilymphocyte Serum
Kidney Transplantation
Rabbits
Graft Rejection
Kidney
Safety
Antibodies
Therapeutics

Keywords

  • High immunological risk
  • Kidney transplantation
  • Rabbit anti-thymocyte globulin

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Rabbit anti-thymocyte globulin : Evidence for clinical benefit in high immunological risk kidney transplantation. / Mai, Martin; Wadei, Hani; Gonwa, Thomas A.

In: Clinical Medicine Insights: Therapeutics, Vol. 3, 2011, p. 39-49.

Research output: Contribution to journalArticle

@article{8686d461b6b141c39e41d0e419b6f392,
title = "Rabbit anti-thymocyte globulin: Evidence for clinical benefit in high immunological risk kidney transplantation",
abstract = "Rabbit anti-thymocyte globulin is used worldwide to treat and prevent rejection in kidney transplantation. Multiple mechanisms of action of this polyclonal preparation are responsible for its success. Studies have supported clinical benefits of rabbit anti-thymocyte globulin in high immunological risk kidney transplant recipients when used as an induction agent at the time of transplant and for treatment of rejection when compared to other antibody therapy. The evidence of this clinical benefit will be reviewed in addition to examining the dosing and safety profile of rabbit anti-thymocyte globulin.",
keywords = "High immunological risk, Kidney transplantation, Rabbit anti-thymocyte globulin",
author = "Martin Mai and Hani Wadei and Gonwa, {Thomas A.}",
year = "2011",
doi = "10.4137/CMT.S3407",
language = "English (US)",
volume = "3",
pages = "39--49",
journal = "Clinical Medicine Insights: Therapeutics",
issn = "1179-559X",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Rabbit anti-thymocyte globulin

T2 - Evidence for clinical benefit in high immunological risk kidney transplantation

AU - Mai, Martin

AU - Wadei, Hani

AU - Gonwa, Thomas A.

PY - 2011

Y1 - 2011

N2 - Rabbit anti-thymocyte globulin is used worldwide to treat and prevent rejection in kidney transplantation. Multiple mechanisms of action of this polyclonal preparation are responsible for its success. Studies have supported clinical benefits of rabbit anti-thymocyte globulin in high immunological risk kidney transplant recipients when used as an induction agent at the time of transplant and for treatment of rejection when compared to other antibody therapy. The evidence of this clinical benefit will be reviewed in addition to examining the dosing and safety profile of rabbit anti-thymocyte globulin.

AB - Rabbit anti-thymocyte globulin is used worldwide to treat and prevent rejection in kidney transplantation. Multiple mechanisms of action of this polyclonal preparation are responsible for its success. Studies have supported clinical benefits of rabbit anti-thymocyte globulin in high immunological risk kidney transplant recipients when used as an induction agent at the time of transplant and for treatment of rejection when compared to other antibody therapy. The evidence of this clinical benefit will be reviewed in addition to examining the dosing and safety profile of rabbit anti-thymocyte globulin.

KW - High immunological risk

KW - Kidney transplantation

KW - Rabbit anti-thymocyte globulin

UR - http://www.scopus.com/inward/record.url?scp=79953011874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953011874&partnerID=8YFLogxK

U2 - 10.4137/CMT.S3407

DO - 10.4137/CMT.S3407

M3 - Article

VL - 3

SP - 39

EP - 49

JO - Clinical Medicine Insights: Therapeutics

JF - Clinical Medicine Insights: Therapeutics

SN - 1179-559X

ER -